[144] Synovus Financial Corp. SEC Filing

Rhea-AI Filing Summary

Synovus Financial Corp. (SNV) filed a Form 144 notifying a proposed sale of 6,200 common shares through Fidelity Brokerage with an approximate aggregate market value of $313,286. The sale is listed for 08/28/2025 on the NYSE. The shares were acquired mostly through restricted stock vesting: 10 shares vested on 02/16/2025 and 6,190 shares vested on 02/17/2025, both recorded as compensation. The filing reports 138,804,263 shares outstanding, making the proposed sale under 0.005% of outstanding common stock. The filer reports no sales of the issuer's securities in the past three months and affirms no undisclosed material information.

Positive

• Proposed sale is immaterial to capitalization (6,200 shares ≈ 0.0045% of outstanding shares)
• Securities originated from restricted stock vesting, indicating compensation-related liquidity rather than a market-timed disposition
• Filer affirms no undisclosed material information and reports no sales in the past three months

Negative

• Insider selling newly vested shares, which could be interpreted as routine liquidity but is a reduction in insider holdings

Insights

Securities Analyst

TL;DR: Small insider sale of recently vested restricted shares, immaterial to capitalization and likely routine compensation-related liquidity.

The Form 144 shows a proposed sale of 6,200 shares worth approximately $313,286, representing roughly 0.0045% of Synovus's outstanding common stock. Acquisition source is restricted stock vesting and payment is listed as compensation, indicating these shares arose from employee or executive equity awards. There are no prior sales in the past three months reported for this account, and the filer affirms no undisclosed material information. From a market-impact perspective this is immaterial to outstanding float or control; it appears to be a routine disposal of vested compensation.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 mechanics; timing and origin (vesting) are typical for equity compensation.

The notice documents the required seller representation and provides acquisition dates tied to restricted stock vesting on 02/16/2025 and 02/17/2025, with consideration listed as compensation. The use of a broker (Fidelity) and the filing of Form 144 comply with disclosure expectations when restricted shares become eligible for sale. No red flags appear in the filing text: there are no reported prior sales in the three-month window and the filer affirms absence of material nonpublic information at signing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6200	313286.00	138804263	08/28/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/16/2025	Restricted Stock Vesting	Issuer			10	02/16/2025	Compensation
Common	02/17/2025	Restricted Stock Vesting	Issuer			6190	02/17/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Synovus (SNV) Form 144 report?

Form 144 reports a proposed sale of 6,200 common shares via Fidelity with aggregate market value of $313,286, dated for sale on 08/28/2025.

How were the shares acquired that are being sold under Form 144?

The shares were acquired via restricted stock vesting: 10 shares on 02/16/2025 and 6,190 shares on 02/17/2025, recorded as compensation.

What portion of SNV outstanding stock does this proposed sale represent?

Approximately 0.0045% of outstanding common stock (6,200 of 138,804,263 shares outstanding).

Has the filer sold Synovus securities in the past three months?

No, the filing states there were no securities sold during the past three months by the person for whose account the securities are to be sold.

Does the filing indicate any undisclosed material information?

No, the filer represents by signing the notice that they do not know any material adverse information not publicly disclosed.